ConductScience.org, home

Trial · NCT03148756

Results by group14

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Clinical Response at Day 84 in the Intent-to Treat (ITT) PopulationStandard of CareSuccess1Participants
Number of Participants With Clinical Response at Day 84 in the Intent-to Treat (ITT) PopulationStandard of CareFailure0Participants
Percentage of Participants With Clinical Outcome of Success at Day 42 in the ITT PopulationStandard of Care100percentage of participants
Percentage of Participants With Clinical Outcome of Success at Day 42 in the Clinically Evaluable (CE) PopulationStandard of Care100percentage of participants
Number of Participants With Day 84 Mortality in the Safety PopulationStandard of Care0Participants
Percentage of Participants With Clinical Outcome of Success at Day 84 in the CE PopulationStandard of Care100percentage of participants
Percentage of Participants With Clinical Outcome of Success by Pathogen at Day 42 in the ITT PopulationStandard of Care100percentage of participants
Percentage of Participants With Clinical Outcome of Success by Pathogen at Day 84 in the ITT PopulationStandard of Care100percentage of participants
Percentage of Participants With Clinical Outcome of Success by Pathogen at Day 42 in the CE PopulationStandard of Care100percentage of participants
Percentage of Participants With Clinical Outcome of Success by Pathogen at Day 84 in the CE PopulationStandard of Care100percentage of participants
Percentage of Participants With Microbiological Success by Pathogen at Day 42 in the ITT PopulationStandard of Care100percentage of participants
Percentage of Participants With Microbiological Success by Pathogen at Day 84 in the ITT PopulationStandard of Care100percentage of participants
Percentage of Participants With Microbiological Success by Pathogen at Day 42 in the CE PopulationStandard of Care100percentage of participants
Percentage of Participants With Microbiological Success by Pathogen at Day 84 in the CE PopulationStandard of Care100percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03148756/results